Literature DB >> 24453160

Development of novel mechanisms for housing, handling, and remote monitoring of common marmosets at animal biosafety level 3.

Diana S Powell1, Reagan C Walker, Dennis T Heflin, Dan Fisher, Joseph B Kosky, Lesley C Homer, Douglas S Reed, Kelly Stefano-Cole, Anita M Trichel, Amy L Hartman.   

Abstract

The use of common marmosets as an alternative non-human primate model for infectious disease research using BSL-3 viruses such as Rift Valley fever virus (RVFV) presents unique challenges with respect to housing, handling, and safety. Subject matter experts from veterinary care, animal husbandry, biosafety, engineering, and research were consulted to design a pilot experiment using marmosets infected with RVFV. This paper reviews the caging, handling, and safety-related adaptations and modifications that were required to humanely utilize marmosets as a model for high-hazard BSL-3 viral diseases.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Regional Biocontainment Laboratory; Rift Valley fever virus; biosafety level 3; radiotelemetry

Mesh:

Year:  2014        PMID: 24453160     DOI: 10.1111/2049-632X.12140

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  3 in total

1.  Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities.

Authors:  Ming Guo; Yong Wang; Jinbiao Liu; Zhixiang Huang; Xiangdong Li
Journal:  J Biosaf Biosecur       Date:  2019-02-20

2.  The Evaluation of the Containment Efficacy of Semi-Rigid Isolators for Housing Cages of Laboratory Animals Infected With BSL-3 Agents.

Authors:  Louis DeTolla; David K Johnson; Scott D Reynolds; Rigoberto Sanchez; Robert H Weichbrod; Matthew C Terzi
Journal:  ILAR J       Date:  2022-01-07       Impact factor: 1.521

Review 3.  Opportunities for Refinement of Non-Human Primate Vaccine Studies.

Authors:  Mark J Prescott; Carolyn Clark; William E Dowling; Amy C Shurtleff
Journal:  Vaccines (Basel)       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.